Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Public comment period · §3

Draft synthesis: Human evidence for BPC-157 — disposition

The disposition of every submission and the amendments that resulted.

Document identifier
CEI-CP-107/3
Series
Public comment period
Version
1.0
Published
22 Apr 2025
Last reviewed
22 Apr 2025
Next review
22 Apr 2026
Identifier
10.71829/cei.cp.107
Certainty
Not rated
Cycle
2025 Q1
Window
05 Feb 2025 – 02 Apr 2025
Status
Closed
Submissions
4

§3Disposition and amendments

§3.1Disposition table

Table 1. Every submission with its disposition. Each row links to the submission in full.

ReferenceRespondentPoint raisedDisposition
DRAFT-BPC-157-HUMA/001Dr Oisín RautavaaraA funnel plot is presented for a set too small to interpret itAccepted
DRAFT-BPC-157-HUMA/002Ms Rhiannon Okoye-VandergraafPatient-reported outcomes are collected by the trials and not reported by the reviewAccepted in part
DRAFT-BPC-157-HUMA/003Dr Matthias Wintringham industryA sponsor trial meeting the eligibility criteria was excludedAccepted in part
DRAFT-BPC-157-HUMA/004Professor Bartolomeu Nkosi-LindegaardRegulatory assessment documents were not searchedAccepted in part
4 submissions in total.

§3.2Summary by disposition

Table 2. Counts by disposition, with the meaning of each.

DispositionCountMeaning
Accepted1The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.
Accepted in part3Part of the submission is accepted and part is not. The secretariat response states which part is which and on what ground the remainder was declined.
Noted, no amendment0The submission raises a point the Institute accepts but that does not require a change to the draft, most often because the draft already states it elsewhere. The location is given in the response.
Not accepted0The submission is not accepted. The secretariat response gives the reason. A submission that is not accepted remains published in full; the Institute does not remove a submission because it disagrees with it.

§3.3Resulting amendments

  1. A funnel plot is presented for a set too small to interpret it — arising from DRAFT-BPC-157-HUMA/001. The funnel plot is removed for every outcome contributed by fewer than ten studies, and replaced by a statement that small-study effects could not be assessed at that number, together with the count of registered trials identified without posted results.
  2. Patient-reported outcomes are collected by the trials and not reported by the review — arising from DRAFT-BPC-157-HUMA/002. Patient-reported outcomes measured by any contributing trial are now reported narratively by instrument, with the instrument named and its minimum important difference stated where one is published, and the absence of a pooled estimate explained.
  3. A sponsor trial meeting the eligibility criteria was excluded — arising from DRAFT-BPC-157-HUMA/003. The trial is added to the included set, the estimate and the certainty rating have been recomputed, and the screening record now states why the trial was missed, which was a database indexing gap rather than a screening judgement. The submission is identified…
  4. Regulatory assessment documents were not searched — arising from DRAFT-BPC-157-HUMA/004. Published regulatory assessment documents are now searched as a named source, are reported as a distinct evidence class in the included-studies table, and contribute to the assessment while being excluded from pooled estimates where risk of bias could not be…

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.